China Stops Sales Of OTC Pediatric Drugs Containing Amantadine
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA has recently forbidden the use of three top-selling OTC pediatric compounds containing amantadine for infants under the age of 1 for safety and efficacy reasons.